(Q35618789)

9 August 2017

1 reference

title

Management of Wilms' tumour: current practice and future goals (English)

1 reference

9 August 2017

7

0 references

Elizabeth J Perlman

object named as

Elizabeth J Perlman

3

1 reference

ORCID Public Data File 2021

Marcio H Malogolowkin

4

object named as

Marcio Malogolowkin

1 reference

9 August 2017

2

Jeffrey S Dome

1 reference

9 August 2017

John A Kalapurakal

1

1 reference

9 August 2017

Gerald M Haase

5

1 reference

9 August 2017

Paul Grundy

6

1 reference

9 August 2017

publication date

1 January 2004

1 reference

Lancet Oncology Commission

9 August 2017

published in

1 reference

9 August 2017

volume

5

1 reference

9 August 2017

issue

1

1 reference

9 August 2017

page(s)

37-46

1 reference

Incidence of cancer in children in the United States. Sex-, race-, and 1-year age-specific rates by histologic type

9 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901322-6

7 January 2021

Bilateral Wilms' tumor: long-term survival and some epidemiological features

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901322-6

7 January 2021

Role of chest computed tomography at diagnosis in the management of Wilms' tumor: a study by the United Kingdom Children's Cancer Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901322-6

7 January 2021

Use of chest computed tomography for staging and treatment of Wilms' tumor in children

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901322-6

7 January 2021

Wilms tumor and nephroblastomatosis: imaging characteristics at gadolinium-enhanced MR imaging

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901322-6

7 January 2021

US, CT and MR imaging characteristics of nephroblastomatosis

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901322-6

7 January 2021

Wilms' tumor and other renal tumors of childhood: A selective review from the National Wilms' Tumor Study Pathology Center

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901322-6

7 January 2021

Anaplastic Wilms' tumor: clinical and pathologic studies

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901322-6

7 January 2021

Anaplastic Wilms' tumour, a subtype displaying poor prognosis, harbours p53 gene mutations

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901322-6

7 January 2021

New developments in the pathology of Wilms tumor

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901322-6

7 January 2021

Focal versus diffuse anaplasia in Wilms tumor--new definitions with prognostic significance: a report from the National Wilms Tumor Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901322-6

7 January 2021

Response without shrinkage in bilateral Wilms tumor: significance of rhabdomyomatous histology

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901322-6

7 January 2021

Histological analysis of aggressiveness and responsiveness in Wilms' tumor

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901322-6

7 January 2021

Treatment with nephrectomy only for small, stage I/favorable histology Wilms' tumor: a report from the National Wilms' Tumor Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901322-6

7 January 2021

Clinical impact of histologic subtypes in localized non-anaplastic nephroblastoma treated according to the trial and study SIOP-9/GPOH.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901322-6

7 January 2021

Precursor lesions of Wilms tumor: clinical and biological implications

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901322-6

7 January 2021

Factors affecting the risk of contralateral Wilms tumor development: a report from the National Wilms Tumor Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901322-6

7 January 2021

Recent advances in Wilms tumor genetics

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901322-6

7 January 2021

Principles of Wilms' tumor biology

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901322-6

7 January 2021

Evidence that WT1 mutations in Denys — Drash syndrome patients may act in a dominant-negative fashion

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901322-6

7 January 2021

Wilms' tumor. Surgical considerations and controversies

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901322-6

7 January 2021

Controversies in the management of Wilms' tumor

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901322-6

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901322-6

7 January 2021

The treatment of Wilms' tumor. Results of the national Wilms' tumor study

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901322-6

7 January 2021

Percutaneous needle biopsy preceding preoperative chemotherapy in the management of massive renal tumors in children

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901322-6

7 January 2021

Renal failure in Wilms' tumor patients: a report from the National Wilms' Tumor Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901322-6

7 January 2021

Is partial nephrectomy appropriate treatment for unilateral Wilms' tumor?

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901322-6

7 January 2021

Preoperative versus postoperative radiotherapy, single versus multiple courses of actinomycin D, in the treatment of Wilms' tumor. Preliminary results of a controlled clinical trial conducted by the International Society of Paediatric Oncology (S.I.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901322-6

7 January 2021

Results of the Sixth International Society of Pediatric Oncology Wilms' Tumor Trial and Study: a risk-adapted therapeutic approach in Wilms' tumor

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901322-6

7 January 2021

Effectiveness of preoperative chemotherapy in Wilms' tumor: results of an International Society of Paediatric Oncology (SIOP) clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901322-6

7 January 2021

Optimal duration of preoperative therapy in unilateral and nonmetastatic Wilms' tumor in children older than 6 months: results of the Ninth International Society of Pediatric Oncology Wilms' Tumor Trial and Study

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901322-6

7 January 2021

Complete necrosis induced by preoperative chemotherapy in Wilms tumor as an indicator of low risk: report of the international society of paediatric oncology (SIOP) nephroblastoma trial and study 9.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901322-6

7 January 2021

The role of preoperative chemotherapy in the management of Wilms' tumor. The SIOP studies. International Society of Pediatric Oncology

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901322-6

7 January 2021

The new SIOP (Stockholm) working classification of renal tumours of childhood. International Society of Paediatric Oncology.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901322-6

7 January 2021

Results of the United Kingdom Children's Cancer Study Group first Wilms' Tumor Study.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901322-6

7 January 2021

Older age is an adverse prognostic factor in stage I, favorable histology Wilms' tumor treated with vincristine monochemotherapy: a study by the United Kingdom Children's Cancer Study Group, Wilm's Tumor Working Group

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901322-6

7 January 2021

The treatment of Wilms' tumour: results of the United Kingdom Children's cancer study group (UKCCSG) second Wilms' tumour study

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901322-6

7 January 2021

The treatment of Wilms' Tumor: Results of the second national Wilms' Tumor study

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901322-6

7 January 2021

Treatment of Wilms' tumor. Results of the Third National Wilms' Tumor Study

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901322-6

7 January 2021

Comparison between single-dose and divided-dose administration of dactinomycin and doxorubicin for patients with Wilms' tumor: a report from the National Wilms' Tumor Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901322-6

7 January 2021

Effect of duration of treatment on treatment outcome and cost of treatment for Wilms' tumor: a report from the National Wilms' Tumor Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901322-6

7 January 2021

The management of relapsed Wilms tumor.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901322-6

7 January 2021

Etoposide and carboplatin: a highly effective combination in relapsed or refractory Wilms' tumor--a phase II study by the French Society of Pediatric Oncology

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901322-6

7 January 2021

Ifosfamide/carboplatin/etoposide (ICE) for recurrent malignant solid tumors of childhood: a Pediatric Oncology Group Phase I/II study.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901322-6

7 January 2021

Ifosfamide, carboplatin and etoposide in children with poor-risk relapsed Wilms' tumor: a Children's Cancer Group report

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901322-6

7 January 2021

Improved survival for patients with recurrent Wilms tumor: the experience at St. Jude Children's Research Hospital

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901322-6

7 January 2021

Autologous bone marrow transplantation for pediatric Wilms' tumor: the experience of the European Bone Marrow Transplantation Solid Tumor Registry.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901322-6

7 January 2021

High-dose melphalan, etoposide, and carboplatin followed by autologous stem-cell rescue in pediatric high-risk recurrent Wilms' tumor: a French Society of Pediatric Oncology study

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901322-6

7 January 2021

Radiation therapy of Wilms' tumor: Results according to dose, field, post-operative timing and histology

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901322-6

7 January 2021

Abdominal relapses in irradiated second National Wilms' Tumor Study patients

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901322-6

7 January 2021

Results of two radiation therapy randomizations in the third National Wilms' Tumor Study

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901322-6

7 January 2021

Influence of radiation therapy delay on abdominal tumor recurrence in patients with favorable histology Wilms' tumor treated on NWTS-3 and NWTS-4: a report from the National Wilms' Tumor Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901322-6

7 January 2021

Treatment of children with stages II to IV anaplastic Wilms' tumor: a report from the National Wilms' Tumor Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901322-6

7 January 2021

Significance and management of computed tomography detected pulmonary nodules: a report from the National Wilms Tumor Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901322-6

7 January 2021

Congestive heart failure after treatment for Wilms' tumor: a report from the National Wilms' Tumor Study group

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901322-6

7 January 2021

Pregnancy outcome after treatment for Wilms tumor: a report from the National Wilms Tumor Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901322-6

7 January 2021

Late orthopedic effects in children with Wilms' tumor treated with abdominal irradiation.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901322-6

7 January 2021

Secondary acute myelogenous leukemia in patients previously treated for childhood renal tumors: a report from the National Wilms Tumor Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901322-6

7 January 2021

Second malignant neoplasms following treatment for Wilm's tumor: a report from the National Wilms' Tumor Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901322-6

7 January 2021

10.1016/S1470-2045(03)01322-6

Identifiers

DOI

1 reference

9 August 2017

1 reference